Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TINF2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | TMEM119 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | PTPRD | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | SARS | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | PSMD2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | EME1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | IFT46 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | HOXB6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | DNAJC8 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | RNASEL | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |